Global Preclinical CRO Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	152 Pages	TechNavio	June, 2023	INF18118616

Best Price Guarantee
Price	from $2,500
Length	152 Pages
Publisher	TechNavio
Published Date	June, 2023
SKU	INF18118616

Global Preclinical CRO Market 2023-2027

The preclinical CRO market is forecasted to grow by USD 2253.55 mn during 2022-2027, accelerating at a CAGR of 7.71% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.

Technavio's preclinical CRO market is segmented as below:

By End-user

Pharmaceutical and biopharmaceutical companies
Medical device companies
Academic institutes

By Service

Toxicology testing
Bioanalysis and DMPK studies
Compound management
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical CRO market growth during the next few years. Also, rise in R and D budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical CRO market covers the following areas:

Preclinical CRO market sizing
Preclinical CRO market forecast
Preclinical CRO market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical CRO market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON plc, Imavita S.A.S., IQVIA Inc., JSR Corp., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., Thermo Fisher Scientific Inc., Veeda Clinical Research Ltd., WuXi AppTec Co. Ltd., and Vivotecnia. Also, the preclinical CRO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Service; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global preclinical CRO market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global preclinical cro market 2017 - 2021 ($ million); 4.2 End-user Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million); 4.3 Service Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Service Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2022-2027 (%); Exhibit 31: Data Table on End-user - Market share 2022-2027 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027; Exhibit 34: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%); 6.4 Medical device companies - Market size and forecast 2022-2027; Exhibit 38: Chart on Medical device companies - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Medical device companies - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%); 6.5 Academic institutes - Market size and forecast 2022-2027; Exhibit 42: Chart on Academic institutes - Market size and forecast 2022-2027 ($ million); Exhibit 43: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ million); Exhibit 44: Chart on Academic institutes - Year-over-year growth 2022-2027 (%); Exhibit 45: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Service: 7.1 Market segments; Exhibit 48: Chart on Service - Market share 2022-2027 (%); Exhibit 49: Data Table on Service - Market share 2022-2027 (%); 7.2 Comparison by Service; Exhibit 50: Chart on Comparison by Service; Exhibit 51: Data Table on Comparison by Service; 7.3 Toxicology testing - Market size and forecast 2022-2027; Exhibit 52: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ million); Exhibit 53: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ million); Exhibit 54: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%); Exhibit 55: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%); 7.4 Bioanalysis and DMPK studies - Market size and forecast 2022-2027; Exhibit 56: Chart on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million); Exhibit 57: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million); Exhibit 58: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%); 7.5 Compound management - Market size and forecast 2022-2027; Exhibit 60: Chart on Compound management - Market size and forecast 2022-2027 ($ million); Exhibit 61: Data Table on Compound management - Market size and forecast 2022-2027 ($ million); Exhibit 62: Chart on Compound management - Year-over-year growth 2022-2027 (%); Exhibit 63: Data Table on Compound management - Year-over-year growth 2022-2027 (%); 7.6 Others - Market size and forecast 2022-2027; Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%); 7.7 Market opportunity by Service; Exhibit 68: Market opportunity by Service ($ million); Exhibit 69: Data Table on Market opportunity by Service ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 Germany - Market size and forecast 2022-2027; Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.9 UK - Market size and forecast 2022-2027; Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.10 Canada - Market size and forecast 2022-2027; Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%); 9.11 China - Market size and forecast 2022-2027; Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Altasciences; Exhibit 119: Altasciences - Overview; Exhibit 120: Altasciences - Product / Service; Exhibit 121: Altasciences - Key offerings; 12.4 AmplifyBio; Exhibit 122: AmplifyBio - Overview; Exhibit 123: AmplifyBio - Product / Service; Exhibit 124: AmplifyBio - Key offerings; 12.5 Charles River Laboratories International Inc.; Exhibit 125: Charles River Laboratories International Inc. - Overview; Exhibit 126: Charles River Laboratories International Inc. - Business segments; Exhibit 127: Charles River Laboratories International Inc. - Key news; Exhibit 128: Charles River Laboratories International Inc. - Key offerings; Exhibit 129: Charles River Laboratories International Inc. - Segment focus; 12.6 Eurofins Scientific SE; Exhibit 130: Eurofins Scientific SE - Overview; Exhibit 131: Eurofins Scientific SE - Business segments; Exhibit 132: Eurofins Scientific SE - Key news; Exhibit 133: Eurofins Scientific SE - Key offerings; Exhibit 134: Eurofins Scientific SE - Segment focus; 12.7 ICON plc; Exhibit 135: ICON plc - Overview; Exhibit 136: ICON plc - Product / Service; Exhibit 137: ICON plc - Key offerings; 12.8 Imavita S.A.S.; Exhibit 138: Imavita S.A.S. - Overview; Exhibit 139: Imavita S.A.S. - Product / Service; Exhibit 140: Imavita S.A.S. - Key offerings; 12.9 IQVIA Inc.; Exhibit 141: IQVIA Inc. - Overview; Exhibit 142: IQVIA Inc. - Business segments; Exhibit 143: IQVIA Inc. - Key news; Exhibit 144: IQVIA Inc. - Key offerings; Exhibit 145: IQVIA Inc. - Segment focus; 12.10 JSR Corp.; Exhibit 146: JSR Corp. - Overview; Exhibit 147: JSR Corp. - Business segments; Exhibit 148: JSR Corp. - Key offerings; Exhibit 149: JSR Corp. - Segment focus; 12.11 Kunming Biomed International Ltd.; Exhibit 150: Kunming Biomed International Ltd. - Overview; Exhibit 151: Kunming Biomed International Ltd. - Product / Service; Exhibit 152: Kunming Biomed International Ltd. - Key offerings; 12.12 Laboratory Corp. of America Holdings; Exhibit 153: Laboratory Corp. of America Holdings - Overview; Exhibit 154: Laboratory Corp. of America Holdings - Business segments; Exhibit 155: Laboratory Corp. of America Holdings - Key news; Exhibit 156: Laboratory Corp. of America Holdings - Key offerings; Exhibit 157: Laboratory Corp. of America Holdings - Segment focus; 12.13 Medpace Holdings Inc.; Exhibit 158: Medpace Holdings Inc. - Overview; Exhibit 159: Medpace Holdings Inc. - Product / Service; Exhibit 160: Medpace Holdings Inc. - Key offerings; 12.14 Thermo Fisher Scientific Inc.; Exhibit 161: Thermo Fisher Scientific Inc. - Overview; Exhibit 162: Thermo Fisher Scientific Inc. - Business segments; Exhibit 163: Thermo Fisher Scientific Inc. - Key news; Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus; 12.15 Veeda Clinical Research Ltd.; Exhibit 166: Veeda Clinical Research Ltd. - Overview; Exhibit 167: Veeda Clinical Research Ltd. - Product / Service; Exhibit 168: Veeda Clinical Research Ltd. - Key offerings; 12.16 Vivotecnia; Exhibit 169: Vivotecnia - Overview; Exhibit 170: Vivotecnia - Product / Service; Exhibit 171: Vivotecnia - Key offerings; 12.17 WuXi AppTec Co. Ltd.; Exhibit 172: WuXi AppTec Co. Ltd. - Overview; Exhibit 173: WuXi AppTec Co. Ltd. - Business segments; Exhibit 174: WuXi AppTec Co. Ltd. - Key offerings; Exhibit 175: WuXi AppTec Co. Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 176: Inclusions checklist; Exhibit 177: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 178: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 179: Research methodology; Exhibit 180: Validation techniques employed for market sizing; Exhibit 181: Information sources; 13.5 List of abbreviations; Exhibit 182: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Service; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global preclinical cro market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Service Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on End-user - Market share 2022-2027 (%); Exhibits31: Data Table on End-user - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Medical device companies - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Medical device companies - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%); Exhibits42: Chart on Academic institutes - Market size and forecast 2022-2027 ($ million); Exhibits43: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ million); Exhibits44: Chart on Academic institutes - Year-over-year growth 2022-2027 (%); Exhibits45: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Service - Market share 2022-2027 (%); Exhibits49: Data Table on Service - Market share 2022-2027 (%); Exhibits50: Chart on Comparison by Service; Exhibits51: Data Table on Comparison by Service; Exhibits52: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ million); Exhibits53: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ million); Exhibits54: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%); Exhibits55: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%); Exhibits56: Chart on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million); Exhibits57: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million); Exhibits58: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%); Exhibits60: Chart on Compound management - Market size and forecast 2022-2027 ($ million); Exhibits61: Data Table on Compound management - Market size and forecast 2022-2027 ($ million); Exhibits62: Chart on Compound management - Year-over-year growth 2022-2027 (%); Exhibits63: Data Table on Compound management - Year-over-year growth 2022-2027 (%); Exhibits64: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits65: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits66: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits67: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits68: Market opportunity by Service ($ million); Exhibits69: Data Table on Market opportunity by Service ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%); Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2022 and 2027; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Altasciences - Overview; Exhibits120: Altasciences - Product / Service; Exhibits121: Altasciences - Key offerings; Exhibits122: AmplifyBio - Overview; Exhibits123: AmplifyBio - Product / Service; Exhibits124: AmplifyBio - Key offerings; Exhibits125: Charles River Laboratories International Inc. - Overview; Exhibits126: Charles River Laboratories International Inc. - Business segments; Exhibits127: Charles River Laboratories International Inc. - Key news; Exhibits128: Charles River Laboratories International Inc. - Key offerings; Exhibits129: Charles River Laboratories International Inc. - Segment focus; Exhibits130: Eurofins Scientific SE - Overview; Exhibits131: Eurofins Scientific SE - Business segments; Exhibits132: Eurofins Scientific SE - Key news; Exhibits133: Eurofins Scientific SE - Key offerings; Exhibits134: Eurofins Scientific SE - Segment focus; Exhibits135: ICON plc - Overview; Exhibits136: ICON plc - Product / Service; Exhibits137: ICON plc - Key offerings; Exhibits138: Imavita S.A.S. - Overview; Exhibits139: Imavita S.A.S. - Product / Service; Exhibits140: Imavita S.A.S. - Key offerings; Exhibits141: IQVIA Inc. - Overview; Exhibits142: IQVIA Inc. - Business segments; Exhibits143: IQVIA Inc. - Key news; Exhibits144: IQVIA Inc. - Key offerings; Exhibits145: IQVIA Inc. - Segment focus; Exhibits146: JSR Corp. - Overview; Exhibits147: JSR Corp. - Business segments; Exhibits148: JSR Corp. - Key offerings; Exhibits149: JSR Corp. - Segment focus; Exhibits150: Kunming Biomed International Ltd. - Overview; Exhibits151: Kunming Biomed International Ltd. - Product / Service; Exhibits152: Kunming Biomed International Ltd. - Key offerings; Exhibits153: Laboratory Corp. of America Holdings - Overview; Exhibits154: Laboratory Corp. of America Holdings - Business segments; Exhibits155: Laboratory Corp. of America Holdings - Key news; Exhibits156: Laboratory Corp. of America Holdings - Key offerings; Exhibits157: Laboratory Corp. of America Holdings - Segment focus; Exhibits158: Medpace Holdings Inc. - Overview; Exhibits159: Medpace Holdings Inc. - Product / Service; Exhibits160: Medpace Holdings Inc. - Key offerings; Exhibits161: Thermo Fisher Scientific Inc. - Overview; Exhibits162: Thermo Fisher Scientific Inc. - Business segments; Exhibits163: Thermo Fisher Scientific Inc. - Key news; Exhibits164: Thermo Fisher Scientific Inc. - Key offerings; Exhibits165: Thermo Fisher Scientific Inc. - Segment focus; Exhibits166: Veeda Clinical Research Ltd. - Overview; Exhibits167: Veeda Clinical Research Ltd. - Product / Service; Exhibits168: Veeda Clinical Research Ltd. - Key offerings; Exhibits169: Vivotecnia - Overview; Exhibits170: Vivotecnia - Product / Service; Exhibits171: Vivotecnia - Key offerings; Exhibits172: WuXi AppTec Co. Ltd. - Overview; Exhibits173: WuXi AppTec Co. Ltd. - Business segments; Exhibits174: WuXi AppTec Co. Ltd. - Key offerings; Exhibits175: WuXi AppTec Co. Ltd. - Segment focus; Exhibits176: Inclusions checklist; Exhibits177: Exclusions checklist; Exhibits178: Currency conversion rates for US$; Exhibits179: Research methodology; Exhibits180: Validation techniques employed for market sizing; Exhibits181: Information sources; Exhibits182: List of abbreviations